Lau Victor, VanderZwaag Jared, Murray Colin J, Tremblay Marie-Ève
Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada.
Institute on Aging and Lifelong Health (IALH), University of Victoria, Victoria, British Columbia, Canada.
J Neurochem. 2025 Jun;169(6):e70086. doi: 10.1111/jnc.70086.
Alzheimer's disease (AD) involves cognitive decline, possibly via multiple concurrent pathologies associated with iron accumulation. To investigate if iron accumulation in AD is more likely due to pathological iron-rich compartments, or a compensatory response of iron within oligodendrocytes to disease progression, we sought to quantify iron-rich staining (via Perl's diaminobenzidine; DAB). Healthy wild-type (WT) and APP-PS1Δe9 (APP-PS1; amyloid-beta overexpressing) male mice were examined during middle age, at 14 months. The frontal cortex, a brain region affected over the course of dementia progression, was investigated. Iron-rich compartments were found across genotypes, including oligodendrocytes and immune cells at the blood-brain barrier, and exclusively amyloid plaques in the APP-PS1 genotype. A semi-automated approach was employed to quantify the staining intensity of iron-rich compartments with light microscopy. Mouse frontal cortex of each genotype was also assessed qualitatively and ultrastructurally with scanning electron microscopy, to novelly discern and confirm iron-rich staining (via Perl's DAB). We found parenchymal iron staining corresponding to oligodendrocytes, pericytes, astrocytes, microglia and/or infiltrating macrophages, and amyloid plaques; increased iron deposition and clustering were detected in middle-aged male APP-PS1 versus WT frontal cortex, supporting that AD pathology may involve greater brain iron levels and local clustering. Unexpectedly, iron-rich cells were enriched at the central nervous system (CNS) interface and perivascular space in control and APP-PS1 mouse models, with ultrastructural examination revealing examples of these cells loaded with many secretory granules containing iron. Together, our results provide novel exploration and confirmation of iron-rich cells/compartments in scanning electron microscopy and reinforce literature that iron deposition is relatively increased in AD over healthy cognitive aging and involves greater local clusters of iron burden. Increased iron burden along the aging trajectory, regardless of cognitive status, may also be attributed to novelly discovered iron-rich cells secreting granules along the CNS border.
阿尔茨海默病(AD)会导致认知能力下降,可能是通过与铁蓄积相关的多种并发病理过程。为了研究AD中铁蓄积更可能是由于富含铁的病理性区室,还是少突胶质细胞内铁对疾病进展的代偿反应,我们试图量化富含铁的染色(通过佩尔斯二氨基联苯胺;DAB)。在中年时,即14个月大时,对健康的野生型(WT)和APP-PS1Δe9(APP-PS1;淀粉样β蛋白过表达)雄性小鼠进行了检查。研究了额叶皮质,这是一个在痴呆症进展过程中受到影响的脑区。在所有基因型中都发现了富含铁的区室,包括少突胶质细胞和血脑屏障处的免疫细胞,而在APP-PS1基因型中则仅发现了淀粉样斑块。采用半自动方法通过光学显微镜量化富含铁的区室的染色强度。还通过扫描电子显微镜对每种基因型的小鼠额叶皮质进行了定性和超微结构评估,以新颖地辨别和确认富含铁的染色(通过佩尔斯DAB)。我们发现实质铁染色对应于少突胶质细胞、周细胞、星形胶质细胞、小胶质细胞和/或浸润的巨噬细胞以及淀粉样斑块;与WT额叶皮质相比,中年雄性APP-PS1小鼠额叶皮质中检测到铁沉积增加和聚集,这支持了AD病理可能涉及更高的脑铁水平和局部聚集。出乎意料的是,在对照和APP-PS1小鼠模型中,富含铁的细胞在中枢神经系统(CNS)界面和血管周围间隙富集,超微结构检查显示这些细胞中有许多含有铁的分泌颗粒。总之,我们的结果在扫描电子显微镜下对富含铁的细胞/区室进行了新颖的探索和确认,并强化了文献报道,即与健康的认知衰老相比,AD中铁沉积相对增加,且涉及更大的局部铁负荷簇。无论认知状态如何,沿着衰老轨迹铁负荷增加也可能归因于新发现的沿CNS边界分泌颗粒的富含铁的细胞。